169 related articles for article (PubMed ID: 15035421)
41. Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors.
Klotz U
Swiss Med Wkly; 2005 Mar; 135(11-12):166-8. PubMed ID: 15846528
[No Abstract] [Full Text] [Related]
42. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Becker MC; Wang TH; Wisniewski L; Wolski K; Libby P; Lüscher TF; Borer JS; Mascette AM; Husni ME; Solomon DH; Graham DY; Yeomans ND; Krum H; Ruschitzka F; Lincoff AM; Nissen SE;
Am Heart J; 2009 Apr; 157(4):606-12. PubMed ID: 19332185
[TBL] [Abstract][Full Text] [Related]
43. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib.
Hinz B; Dormann H; Brune K
Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545
[TBL] [Abstract][Full Text] [Related]
44. Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis?
Zeng C; Wei J; Lei GH
Ann Rheum Dis; 2015 May; 74(5):e37. PubMed ID: 25749051
[No Abstract] [Full Text] [Related]
45. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
Meyer CH
Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404
[No Abstract] [Full Text] [Related]
46. [General practice study of therapy of acute pain. Patients prefer cox-2 inhibitors].
MMW Fortschr Med; 2004 May; 146(21):61. PubMed ID: 15373091
[No Abstract] [Full Text] [Related]
47. Coxibs and cardiovascular risk.
Allen MJ; McLean-Veysey P; Fleming I
CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
[No Abstract] [Full Text] [Related]
48. Do that to me one more time! What kind of trial replications do we need?
Lüdtke R
Complement Ther Med; 2008 Aug; 16(4):181-2. PubMed ID: 18638707
[No Abstract] [Full Text] [Related]
49. [Cyclooxygenase-2 inhibitors in postoperative pain management].
Güneş Y; Işik G
Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
[TBL] [Abstract][Full Text] [Related]
50. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
[TBL] [Abstract][Full Text] [Related]
51. Digging for data from the COX-2 trials.
McCormack JP; Rangno R
CMAJ; 2002 Jun; 166(13):1649-50. PubMed ID: 12126315
[No Abstract] [Full Text] [Related]
52. Drug testing. Massive trial of Celebrex seeks to settle safety concerns.
Couzin J
Science; 2005 Dec; 310(5756):1890-1. PubMed ID: 16373546
[No Abstract] [Full Text] [Related]
53. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
54. Superiority, equivalence, and non-inferiority trials.
Lesaffre E
Bull NYU Hosp Jt Dis; 2008; 66(2):150-4. PubMed ID: 18537788
[TBL] [Abstract][Full Text] [Related]
55. COX-2 inhibitors and hypercoagulability.
Farkouh ME
Clin Adv Hematol Oncol; 2005 Jan; 3(1):35-6. PubMed ID: 16166966
[No Abstract] [Full Text] [Related]
56. The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress.
Hawk E; Viner JL
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):185-7. PubMed ID: 17301246
[No Abstract] [Full Text] [Related]
57. Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Jan; 60(1):7-13. PubMed ID: 15652362
[TBL] [Abstract][Full Text] [Related]
58. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
Montuschi P; Macagno F; Parente P; Valente S; Lauriola L; Ciappi G; Kharitonov SA; Barnes PJ; Ciabattoni G
Thorax; 2005 Oct; 60(10):827-33. PubMed ID: 16192367
[TBL] [Abstract][Full Text] [Related]
59. [Double blockade should protect the stomach. New approach to rheumatism].
MMW Fortschr Med; 2001 Sep; 143(38):58. PubMed ID: 11601098
[No Abstract] [Full Text] [Related]
60. Homeopathic treatment of childhood diarrhea.
Fisher P; Dantas F; Reilly D
Pediatrics; 1996 May; 97(5):776; author reply 777-8. PubMed ID: 8628630
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
